141 related articles for article (PubMed ID: 10574946)
21. Nef proteins of distinct HIV-1 or -2 isolates differ in their binding properties for HCK: isolation of a novel Nef binding factor with characteristics of an adaptor protein.
Karn T; Hock B; Holtrich U; Adamski M; Strebhardt K; Rübsamen-Waigmann H
Virology; 1998 Jun; 246(1):45-52. PubMed ID: 9656992
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain.
Lee CH; Saksela K; Mirza UA; Chait BT; Kuriyan J
Cell; 1996 Jun; 85(6):931-42. PubMed ID: 8681387
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity.
Greenway A; Azad A; Mills J; McPhee D
J Virol; 1996 Oct; 70(10):6701-8. PubMed ID: 8794306
[TBL] [Abstract][Full Text] [Related]
24. Capacity of simian immunodeficiency virus strain mac Nef for high-affinity Src homology 3 (SH3) binding revealed by ligand-tailored SH3 domains.
Hiipakka M; Saksela K
J Gen Virol; 2002 Dec; 83(Pt 12):3147-3152. PubMed ID: 12466492
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines.
Greenway A; Azad A; McPhee D
J Virol; 1995 Mar; 69(3):1842-50. PubMed ID: 7853525
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 Nef interferes with M-CSF receptor signaling through Hck activation and inhibits M-CSF bioactivities.
Suzu S; Harada H; Matsumoto T; Okada S
Blood; 2005 Apr; 105(8):3230-7. PubMed ID: 15626739
[TBL] [Abstract][Full Text] [Related]
27. Competitive displacement of full-length HIV-1 Nef from the Hck SH3 domain by a high-affinity artificial peptide.
Stangler T; Tran T; Hoffmann S; Schmidt H; Jonas E; Willbold D
Biol Chem; 2007 Jun; 388(6):611-5. PubMed ID: 17552908
[TBL] [Abstract][Full Text] [Related]
28. Reading between the lines: SH3 recognition of an intact protein.
Lim WA
Structure; 1996 Jun; 4(6):657-9. PubMed ID: 8805558
[TBL] [Abstract][Full Text] [Related]
29. Interaction with the Src homology (SH3-SH2) region of the Src-family kinase Hck structures the HIV-1 Nef dimer for kinase activation and effector recruitment.
Alvarado JJ; Tarafdar S; Yeh JI; Smithgall TE
J Biol Chem; 2014 Oct; 289(41):28539-53. PubMed ID: 25122770
[TBL] [Abstract][Full Text] [Related]
30. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase.
Grzesiek S; Bax A; Clore GM; Gronenborn AM; Hu JS; Kaufman J; Palmer I; Stahl SJ; Wingfield PT
Nat Struct Biol; 1996 Apr; 3(4):340-5. PubMed ID: 8599760
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.
Poghosyan Z; Robbins SM; Houslay MD; Webster A; Murphy G; Edwards DR
J Biol Chem; 2002 Feb; 277(7):4999-5007. PubMed ID: 11741929
[TBL] [Abstract][Full Text] [Related]
32. SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts.
Briggs SD; Smithgall TE
J Biol Chem; 1999 Sep; 274(37):26579-83. PubMed ID: 10473622
[TBL] [Abstract][Full Text] [Related]
33. The accessory factor Nef links HIV-1 to Tec/Btk kinases in an Src homology 3 domain-dependent manner.
Tarafdar S; Poe JA; Smithgall TE
J Biol Chem; 2014 May; 289(22):15718-28. PubMed ID: 24722985
[TBL] [Abstract][Full Text] [Related]
34. The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck.
Hanna Z; Weng X; Kay DG; Poudrier J; Lowell C; Jolicoeur P
J Virol; 2001 Oct; 75(19):9378-92. PubMed ID: 11533201
[TBL] [Abstract][Full Text] [Related]
35. Remodeling of HIV-1 Nef Structure by Src-Family Kinase Binding.
Moroco JA; Alvarado JJ; Staudt RP; Shi H; Wales TE; Smithgall TE; Engen JR
J Mol Biol; 2018 Feb; 430(3):310-321. PubMed ID: 29258818
[TBL] [Abstract][Full Text] [Related]
36. New impressions of Src and Hck.
Pawson T
Nature; 1997 Feb; 385(6617):582-3, 585. PubMed ID: 9024653
[No Abstract] [Full Text] [Related]
37. Use of the two-hybrid system to identify cellular partners of the HIV1 Nef protein.
Benichou S; Liu LX; Erdtmann L; Selig L; Benarous R
Res Virol; 1997; 148(1):71-3. PubMed ID: 9017839
[No Abstract] [Full Text] [Related]
38. Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions.
Bouchet J; Hérate C; Guenzel CA; Vérollet C; Järviluoma A; Mazzolini J; Rafie S; Chames P; Baty D; Saksela K; Niedergang F; Maridonneau-Parini I; Benichou S
J Virol; 2012 May; 86(9):4856-67. PubMed ID: 22345475
[TBL] [Abstract][Full Text] [Related]
39. Activation of the PAK-related kinase by human immunodeficiency virus type 1 Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex.
Brown A; Wang X; Sawai E; Cheng-Mayer C
J Virol; 1999 Dec; 73(12):9899-907. PubMed ID: 10559302
[TBL] [Abstract][Full Text] [Related]
40. The identification of a small molecule compound that reduces HIV-1 Nef-mediated viral infectivity enhancement.
Chutiwitoonchai N; Hiyoshi M; Mwimanzi P; Ueno T; Adachi A; Ode H; Sato H; Fackler OT; Okada S; Suzu S
PLoS One; 2011; 6(11):e27696. PubMed ID: 22110726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
